MacroGenics Inc. (MGNX) News Headlines

▮ More

Date

Headline

12/9/2022 8:09:48 AM 52 Biotech Stocks Of 2022 With Triple-Digit Gains

10/17/2022 7:56:42 AM Gilead, MacroGenics In Deal To Develop Bispecific Antibodies

10/17/2022 7:33:05 AM Gilead Sciences, MacroGenics Announce Oncology Collaboration To Develop Bispecific Antibodies

7/20/2022 7:16:07 AM Pre-market Movers: ELBM, SDIG, GP, RVMD, MGNX…

2/28/2022 7:13:41 AM MacroGenics Promotes Eric Risser To COO

9/28/2021 8:53:52 AM I-Mab Reports Acceptance Of IND Application In China For Phase 2 Trial With Enoblituzumab

2/11/2021 4:42:22 PM MacroGenics Adds Federica O’Brien To Its Board

7/18/2019 9:07:27 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $27 Price Target

6/5/2019 8:51:53 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $27 Up From $26 Price Target

5/16/2019 6:44:44 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $26 Price Target

5/3/2019 8:39:47 AM Wedbush Ups MacroGenics Inc. (MGNX) To Outperform From Neutral With $26 Price Target

2/7/2019 8:24:09 AM Wedbush Cuts MacroGenics Inc. (MGNX) To Neutral From Outperform With $26 Up From $20 Price Target

1/22/2019 7:49:39 AM Wedbush Is Increasing MacroGenics Inc. (MGNX) FY18 Rev. Estimate To 60.3 M From 44.0 M

1/22/2019 7:49:15 AM Wedbush Is Raising MacroGenics Inc. (MGNX) FY18 Estimate To -4.13 From -5.00

1/22/2019 7:30:49 AM Wedbush Is Increasing MacroGenics Inc. (MGNX) Q4 18 Estimate To -0.95 From -1.21

1/22/2019 7:30:19 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $20 Down From $44 Price Target

5/8/2018 8:54:01 AM Wedbush Is Lowering MacroGenics Inc. (MGNX) FY18 Rev. Estimate To 12.3 M From 15.7 M

5/8/2018 8:53:41 AM Wedbush Is Lowering MacroGenics Inc. (MGNX) FY18 Estimate To -5.31 From -4.80

5/8/2018 8:53:25 AM Wedbush Is Lowering MacroGenics Inc. (MGNX) Q4 18 Estimate To -1.39 From -1.17

5/8/2018 8:53:13 AM Wedbush Is Lowering MacroGenics Inc. (MGNX) Q3 18 Estimate To -1.35 From -1.33

Macrogenics Inc. (MGNX)